Prevalence of vitamin D insufficiency/deficiency in rheumatoid arthritis and associations with disease severity and activity

Journal of Rheumatology

Volumn 38, Issue 1, 2011, Pages 53-59

  Kerr, Gail S ^a   Sabahi, Iraj ^b   Richards, John S ^a   Caplan, Liron ^c   Cannon, Grant W ^d   Reimold, Andreas ^c   Thiele, Geoffrey M ^e   Johnson, Dannette ^f   Mikuls, Ted R ^e  

^a HOWARD UNIVERSITY   (United States)

^b WASHINGTON HOSPITAL CENTER   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d UNIVERSITY OF UTAH   (United States)

^e UNIVERSITY OF NEBRASKA LINCOLN   (United States)

^f UNIVERSITY OF MISSISSIPPI   (United States)

Author keywords

25 hydroxyl vitamin D; Anti cyclic citrullinated peptide; Rheumatoid arthritis; US veterans

Indexed keywords

ABATACEPT; ADALIMUMAB; AURANOFIN; AZATHIOPRINE; C REACTIVE PROTEIN; CALCIFEDIOL; CYCLIC CITRULLINATED PEPTIDE ANTIBODY; CYCLOSPORIN; ETANERCEPT; HYDROXYCHLOROQUINE; INFLIXIMAB; LEFLUNOMIDE; METHOTREXATE; RECOMBINANT INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; RITUXIMAB; SALAZOSULFAPYRIDINE;

ADULT; AGE; AGED; ARTICLE; DISEASE ACTIVITY; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; HUMAN; JOINT EXAMINATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RACE; RADIOIMMUNOASSAY; RHEUMATOID ARTHRITIS; VETERAN; VITAMIN D DEFICIENCY; VITAMIN SUPPLEMENTATION;

AGED; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; FEMALE; HUMANS; MALE; MIDDLE AGED; SEVERITY OF ILLNESS INDEX; VITAMIN D DEFICIENCY;

EID: 78650863958     PISSN: 0315162X     EISSN: 14992752     Source Type: Journal    
DOI: 10.3899/jrheum.100516     Document Type: Article

References (41)

1. Ginde AA, Liu MC, Camargo CA Jr. Demographic differences and trends of vitamin D insufficiency in the US population, 1988-2004. Arch Intern Med 2009;23:626-32.
2. Looker AC, Pfeiffer CM, Lacher DA, Schleicher RL, Picciano MF, Yetley EA. Serum 25-hydroxyvitamin D status of the US population: 1988-1994 compared with 2000-2004. Am J Clin Nutr 2008;88:1519-27.
3. Cherniack EP, Levis S, Troen BR. Hypovitaminosis D: a widespread epidemic. Geriatrics 2008;63:24-30.
4. Krause R, Buhring M, Hopfenmuller W, Holick MF, Sharma AM. Ultraviolet B and blood pressure [letter]. Lancet 1998;352:709-10.
5. Cutolo M. Vitamin D and autoimmune rheumatic diseases. Rheumatology 2009;48:210-2.
6. Krishnan AV, Trump DL, Johnson CS, Feldman D. The role of vitamin D in cancer prevention and treatment. Endocrinol Metab Clin North Am 2010;39:401-18.
7. Anderson LN, Cotterchio M, Vieth R, Knight JA. Vitamin D and calcium intakes and breast cancer risk in pre- and postmenopausal women. Am J Clin Nutr 2010;91:1699-707.
8. Karlsson S, Olausson J, Lundh D, Sogard P, Mandal A, Holmstrom KO, et al. Vitamin D and prostate cancer: The role of membrane initiated signaling pathways in prostate cancer progression. J Steroid Biochem Mol Biol 2010;121:413-6.
9. Tse AK, Zhu GY, Wan CK, Shen XL, Yu ZL, Fong WF. 1alpha,25- Dihydroxyvitamin D3 inhibits transcriptional potential of nuclear factor kappa B in breast cancer cells. Mol Immunol 2010;47:1728-38.
10. Liao KP, Alfredsson L, Karlson EW. Environmental influences on risk for rheumatoid arthritis. Curr Opin Rheumatol 2009;21:279-83.
11. Nielen MM, van Schaardenburg D, Lems WF, van de Stadt RJ, de Koning MH, Reesink HW, et al. Vitamin D deficiency does not increase the risk of rheumatoid arthritis. Arthritis Rheum 2006;54:3719-20.
12. Costenbader KH, Feskanich D, Holmes M, Karlson EW, Benito-Garcia E. Vitamin D intake and risks of systemic lupus erythematosus and rheumatoid arthritis in women. Ann Rheum Dis 2008;67:530-5.
13. Merlino LA, Curtis J, Mikuls TR, Cerhan JR, Criswell LA, Saag KG. Vitamin D intake is inversely associated with rheumatoid arthritis: results from the Iowa Women's Health Study. Arthritis Rheum 2004;50:72-7.
14. Patel S, Farragher T, Berry J, Bunn D, Silman A, Symmons D. Association between serum vitamin D metabolite levels and disease activity in patients with early inflammatory polyarthritis. Arthritis Rheum 2007;56:2143-9.
15. Hypponen E, Laara E, Reunanen A, Jarvelin MR, Virtanen SM. Intake of vitamin D and risk of type 1 diabetes: a birth-cohort study. Lancet 2001;358:1500-3.
16. Pittas AG, Dawson-Hughes B, Li T, Van Dam RM, Willett WC, Manson JE, et al. Vitamin D and calcium intake in relation to type 2 diabetes in women. Diabetes Care 2006;29:650-6.
17. Davis CD, Hartmuller V, Freedman DM, Hartge P, Picciano MF, Swanson CA, et al. Vitamin D and cancer: current dilemmas and future needs. Nutr Rev 2007;65:S71-4.
18. Lappe JM, Travers-Gustafson D, Davies KM, Recker RR, Heaney RP. Vitamin D and calcium supplementation reduces cancer risk: results of a randomized trial. Am J Clin Nutr 2007;85:1586-91.
19. Melamed M, Michos E, Post W, Astor B. 25-Hydroxyvitamin D levels and the risk of mortality in the general population. Arch Intern Med 2008;168:1629-37.
20. Martins D, Myles W, Deyu P, Zadshir A, Tareen N, Thadhani R, et al. Prevalence of cardiovascular risk factors and the serum levels of 25-hydroxyvitamin D in the United States. Data from the Third National Health and Nutrition Examination Survey. Arch Intern Med 2007;167:1159-65.
21. Braddy KK, Imam SN, Palla KR, Lee TA. Vitamin D deficiency/insufficiency practice patterns in a Veterans Health Administration long-term care population: a retrospective analysis. J Am Med Dir Assoc 2009;10:653-7.
22. Wortsman J, Matsuoka LY, Chen TC, Lu Z, Holick MF. Decreased bioavailability of vitamin D in obesity. Am J Clin Nutr 2000;72:690-3.
23. Vilarrasa N, Maravall J, Estepa A, Sanchez R, Masdevall C, Navarro MA, et al. Low 25-hydroxyvitamin D concentrations in obese women: their clinical significance and relationship with anthropometric and body composition variables. J Endocrinol Invest 2007;30:653-8.
24. Mikuls TR, Kazi S, Cipher D, Hooker R, Kerr GS, Richards JR, et al. The association of race and ethnicity with disease expression in male US veterans with rheumatoid arthritis. J Rheumatol 2007;34:1480-4.
25. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-24.
26. Holick MF. High prevalence of vitamin D inadequacy and implications for health. Mayo Clin Proc 2006;81:353-73.
27. Cranney A, Horsely T, O'Donnell S, Weiler H, Puil L, Ooi D, et al. Effectiveness and safety of vitamin D in relation to bone health. Evidence Report/Technology Assessment no. 158. Prepared by the University of Ottawa Evidence-based Practice Center under Contract No. 290-02-0021. AHRQ Publication No. 07-E013. Rockville, MD: Agency for Healthcare Research and Quality; 2007.
28. Wolfe F, Michaud K, Pincus T. Development and validation of the Health Assessment Questionnaire II: A revised version of the Health Assessment Questionnaire. Arthritis Rheum 2004; 50:3296-305.
29. Prevoo ML, van 't Hof MA, Kuper HH, van Leeuwen MA, van de Putte LB, van Riel. Modified disease activity scores that include twenty eight-joint counts: development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum 1995;38:44-8.
30. Chaganti RK, Parimi N, Cawthon P, Dam TL, Nevitt MC, Lane NE. Association of 25-hydroxyvitamin D with prevalent osteoarthritis of the hip in elderly men: The Osteoporotic Fractures in Men Study. Arthritis Rheum 2010;62:511-4.
31. Craig SM, Yu F, Curtis JF, Alarcon GS, Conn DL, Jonas B, et al. Vitamin D status and its associations with disease activity and severity in African Americans with recent-onset rheumatoid arthritis. J Rheumatol 2010;37:275-81.
32. Holick MF. Vitamin D deficiency. N Engl J Med 2007;357:266-81.
33. Nesby-Odell S, Scanlon KS, Cogswell ME, Gillespie C, Hollis BW, Looker AC, et al. Hypovitaminois D prevalence and determinants among African Americans and white women of reproductive age: Third National Health and Nutrition Examination Survey, 1988-1994. Am J Clin Nutr 2002;76:187-92.
34. Cutolo M, Otsa K. Vitamin D, immunity and lupus. Lupus 2008;17:6-10.
35. Als OS, Riis B, Christiansen C. Serum concentration of vitamin D metabolites in rheumatoid arthritis. Clin Rheumatol 1987;6:238-43.
36. Kroger H, Penttila IM, Alhava EM. Low serum vitamin D metabolites in women with rheumatoid arthritis. Scand J Rheumatol 1993;22:172-7.
37. Cutolo M, Otsa K, Laas K, Yprus M, Lehtme R, Secchi ME, et al. Circannual vitamin D serum levels and disease activity in rheumatoid arthritis: Northern versus Southern Europe. Clin Exp Rheumatol 2006;24:702-4.
38. Plotnikoff GA, Quigley JM. Prevalence of severe hypovitaminosis D in patients with persistent, non-specific musculoskeletal pain. Mayo Clin Proc 2003;78:1463-70.
39. Straube S, Moore RA, Derry S, Hallier E, McQuay HJ. Vitamin D and chronic pain in immigrant and ethnic minority patients - Investigation of the relationship and comparison with native Western populations. Int J Endocrinol 2010. Epub 2009 Oct 19.
40. Orbach H, Zandman-Goddard G, Amital H, Barak V, Szekanecz Z, Szucs G, et al. Novel biomarkers in autoimmune diseases: prolactin, ferritin, vitamin D, and TPA levels in autoimmune diseases. Ann NY Acad Sci 2007;1109:385-400.
41. Feser M, Derber LA, Deane KD, Lezotte DC, Weisman MH, Buckner JH, et al. Plasma 25,OH vitamin D concentrations are not associated with rheumatoid arthritis (RA)-related autoantibodies in individuals at elevated risk for RA. J Rheumatol 2009;36:943-6.